blummer

[TimAlerts] $CTIC : "Investigators also analyzed the phase III study based on the 32% of patients enrolled with baseline platelet counts of 100,000 or less. Outside of a clinical trial, these patients would be candidates for treatment with a lowered dose of Jakafi. Here, the pacritinib spleen response was 17% versus zero response for the best alternative therapy." meaning, they are better than INCYTE's Jakafi at treating the same disease. INCYTE is 19$B mkt cap co. Not a fan of their adverse events thou

blummer

[TimAlerts] I think I will play $CTIC today, 150M float, 15.48% short float, 6.96 short ratio... not too happy about the short numbers... but lots of support it seems

blummer

[TimAlerts] I really like the article on $CTIC - they are going up against $INCY (19$B mkt cap), saying their product may be better at treating the same disease

blummer

[TimAlerts] VBLT too much hype on interim results... there will probably be a mini short squeeze, but this one's not for me

blummer

[TimAlerts] $TBIO my broker won't let me trade it online cause it's a OTC... sigh... and i'm using a registered account... but anyway, float is traded +1.5 already..

blummer

[TimAlerts] $TBIO, more than half the volume of yesterday traded.. and market has not opened... this dip is a good send. It's heading to 3.5+ today. I'm going in shortly after opening bell.. will try to watch my sucky level 2s

Received 1 Karma
Page
of 32